Physician profile
Mamoo Nakamura
NPI 1972752467
$82,493.52
in general payments reported to CMS, 2019-2025
12 companies · $2,417 in 2025
The $2,417 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $1,807 · 2021: $9,625 · 2022: $2,772 · 2023: $4,366 · 2024: $10K · 2025: $2,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,353 · Consulting Fee: $5,070 · Travel and Lodging: $4,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,353.11 |
| Consulting Fee | $5,070.00 |
| Travel and Lodging | $4,762.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $45,559.99 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $15,174.54 | 2019-2025 | Emerge Push, Avvigo Guidance System, Sentinel |
| W. L. Gore & Associates, INC. | $13,943.58 | 2021-2024 | Gore Cardioform Septal Occluder, Gore Excluder Aaa Endoprosthesis |
| Abbott Laboratories | $4,128.17 | 2019-2023 | Mitraclip |
| Medtronic, INC. | $2,908.40 | 2022-2025 | Corevalve Evolut R |
| Abiomed | $187.11 | 2025 | |
| Shockwave Medical, INC | $177.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $133.14 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $110.94 | 2019 | |
| Philips North America LLC | $80.42 | 2021-2024 | (Bq9) Coronary Ivus |
| Cardiovascular Systems INC. | $55.66 | 2020 | |
| Recor Medical INC | $33.86 | 2025 | Paradise Ultrasound Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamoo Nakamura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.